UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska explores the challenges and benefits of telemedicine following the COVID-19 pandemic.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Med Ctr, explores the need for improved access to epilepsy surgery.
There are 21 epilepsy-related deaths every week in the UK - here, Maxine Smeaton, Chief Executive of Epilepsy Research UK discusses what the future holds for essential epilepsy treatment research.
Scientists at the University of Nottingham are exploring the potential of new treatment for epilepsy, as they reveal that neuron connections in the brain can be a good indicator of disease progression.
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
A newly developed graphene-based implant can record electrical activity in the brain at extremely low frequencies and over large areas, unlocking the wealth of information found below 0.1 Hz and the potential for new epilepsy treatment.
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
